263 related articles for article (PubMed ID: 10676911)
1. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.
Frickhofen N; Rosenfeld SJ
Semin Hematol; 2000 Jan; 37(1):56-68. PubMed ID: 10676911
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
4. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S; Follmann D; Nunez O; Young NS
JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
[TBL] [Abstract][Full Text] [Related]
7. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
[TBL] [Abstract][Full Text] [Related]
8. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Chandra J; Naithani R; Ravi R; Singh V; Narayan S; Sharma S; Pemde H; Dutta AK
Indian J Pediatr; 2008 Mar; 75(3):229-33. PubMed ID: 18376089
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
10. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
He G; Zhang X; Wu D; Sun A; Wang X
Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
[TBL] [Abstract][Full Text] [Related]
11. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Gupta V; Bhatia B
Indian J Pediatr; 2009 Sep; 76(9):970-1; author reply 971-2. PubMed ID: 19381516
[No Abstract] [Full Text] [Related]
12. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
Scheinberg P; Wu CO; Nunez O; Young NS
J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
[TBL] [Abstract][Full Text] [Related]
13. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
Fang JP; Xu HG; Huang SL; Chen C; Huang K
Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
[TBL] [Abstract][Full Text] [Related]
15. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy for aplastic anemia--review].
Xu CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
[TBL] [Abstract][Full Text] [Related]
18. [Reference guide for the treatment of aplastic anemia: key points of the 2022 revision].
Yamazaki H
Rinsho Ketsueki; 2023; 64(9):892-899. PubMed ID: 37793863
[TBL] [Abstract][Full Text] [Related]
19. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
Sharma R; Chandra J; Sharma S; Pemde H; Singh V
J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Risitano AM
Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]